| Code | 2294E | ||||||||||
| MA number | 58/0272/22-S | ||||||||||
| Product Form: | tbl flm 98x300 mg/12,5 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Swyssi AG, Germany | ||||||||||
| Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PE/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.11.2022 |
| Validity: | 24.11.2027 |
| PIL: |
PIL_Izgrev 300 mg_12,5 mg_11_2022.pdf
|
| SPC: |
SPC_Izgrev 300 mg_12,5 mg_11_2022.pdf
|
| Safety feature | Yes |
| Data update: | 16.12.2022 |
